Literature DB >> 17654183

Intracytoplasmic sperm injection: an assisted reproductive technique and its outcome to overcome infertility.

N N Sarkar1.   

Abstract

This review focuses on the outcome, merits and demerits of intracytoplasmic sperm injection (ICSI) for treatment of male factor infertility. Spermatozoa of infertile men are surgically retrieved from the epididymis or testis. Fertilisation and pregnancy rates after ICSI are found to be around 66% and 48%, respectively, with surgically retrieved spermatozoa. Major contributing factors to failed fertilisation after ICSI are the number of metaphase II oocytes retrieved and availability of viable spermatozoa for injection. Children born after ICSI have an increased risk of major congenital deformity as compared with children born naturally. Both paternal and maternal risk factors seem to pose an increased risk of congenital malformations in the offspring born after ICSI. The ICSI technique per se is not an independent risk factor. Qualitative differences in development and social interaction between ICSI and natural children appears to be related to developmental processes of the entire family unit. Parents of ICSI children have a good relationship with their children.

Entities:  

Mesh:

Year:  2007        PMID: 17654183     DOI: 10.1080/01443610701327339

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  2 in total

1.  Different sperm sources and parameters can influence intracytoplasmic sperm injection outcomes before embryo implantation.

Authors:  Yue-hong Lu; Hui-juan Gao; Bai-jia Li; Ying-ming Zheng; Ying-hui Ye; Yu-li Qian; Chen-ming Xu; He-feng Huang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

2.  Outcome of conventional IVF and ICSI on sibling oocytes in moderate ligoasthenozoospermia.

Authors:  Bao-Guo Xie; Wei-Jie Zhu; Yuan-Hua Huang
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.